bay h 4502 has been researched along with Candidiasis, Vulvovaginal in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kaplan, B; Neri, A; Rabinerson, D; Royburt, M | 1 |
Basi, N; Dronda, MA; Forn, J; GarcĂa Rafanell, J; Merlos, M; Torres, JM; Zapatero, MI | 1 |
1 trial(s) available for bay h 4502 and Candidiasis, Vulvovaginal
Article | Year |
---|---|
Once-daily fluocinonide-bifonazole combination for the treatment of vulvar itching and vulvovaginal candidiasis. Preliminary study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Antifungal Agents; Candidiasis, Vulvovaginal; Drug Combinations; Female; Fluocinonide; Humans; Imidazoles; Middle Aged; Ointments; Treatment Outcome; Vulvovaginitis | 1996 |
1 other study(ies) available for bay h 4502 and Candidiasis, Vulvovaginal
Article | Year |
---|---|
In vitro and in vivo studies with flutrimazole, a new imidazole derivative with antifungal activity.
Topics: Animals; Antifungal Agents; Candidiasis, Vulvovaginal; Clotrimazole; Female; Fungi; Guinea Pigs; Imidazoles; Male; Microbial Sensitivity Tests; Mycoses; Rats; Rats, Wistar; Tinea | 1992 |